Skip to main content

Advertisement

Table 3 Summary of findings in the endoscopic procedure at the end of treatments

From: Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial

Volunteer # Treatment Scores before treatment Cryer Score Lanza Score Antrum Duodenum Other
2 Placebo 0 3 2 4 erosions   
5 Placebo 0 2 1 1 erosion + submucousal hemorrage   
7 Placebo 0 4 4 >20 erosions   
8 Placebo 0 4 5 2 erosions + 1 ulcer (Sakita A2)   
10 Placebo 0 4 4 >10 erosions   
12 Placebo 0 4 5 10 erosions + 1 ulcer (Sakita A2)   
14 Placebo 0 4 2 5 erosions   
16 Placebo 0 4 4 20 erosions   
17 Placebo 0 4 4 10 erosions 3 erosions  
18 Placebo 0 4 4 10 erosions   
19 Placebo 0 4 4 10 erosions   
23 Placebo 0 4 4 10 erosions   
1 Rebamipide 0 4 4 20–25 erosions   
3 Rebamipide 0 4 4 10 erosions   
4 Rebamipide 0 4 5 10 erosions 1 ulcer (Sakita A2)  
6 Rebamipide 0 3 1 2 erosions + erythema   
9 Rebamipide 0 3 2 3 erosions   
11 Rebamipide 0 3 3 2 erosions   Submucousal hemorrhage in gastric fundus
13 Rebamipide 0 5 5 Small erosions + 2 ulcers (Sakita A2)   
15 Rebamipide 0 4 2 5 erosions + erythema   
20 Rebamipide 0 3 2 4 erosions   
21 Rebamipide 0 4 5    Pylorus with edema and 1 ulcer (Sakita A2)
22 Rebamipide 0 3 2 3 erosions   
24 Rebamipide 0 5 5 10 erosions + 4 ulcers (Sakita A2)